SK BIOSCIENCE LOOKING AT AN IPO MONEYSPINNER WITH ASTRAZENECA COVID-19 VACCINE DEAL

• Ever since a deal was reached in July for SK Bioscience to manufacture AstraZeneca's COVID-19 vaccine, the SK subsidiary has already succeeded in producing the vaccine at its Andong L HOUSE vaccine center.
• While some vials of the vaccine produced have already been exported, SK Bioscience has put its mind to production for the domestic market.

This was after a deal being inked recently between the Korean....